Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic …
Five biologicals have been approved for severe eosinophilic asthma, a well‐recognized
phenotype. Systematic reviews (SR) evaluated the efficacy and safety of benralizumab …
phenotype. Systematic reviews (SR) evaluated the efficacy and safety of benralizumab …
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines
This systematic review evaluates the efficacy and safety of biologicals for chronic
rhinosinusitis with nasal polyps (CRSwNP) compared with the standard of care. PubMed …
rhinosinusitis with nasal polyps (CRSwNP) compared with the standard of care. PubMed …
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: a systematic review for the EAACI Guidelines …
Allergic asthma is a frequent asthma phenotype. Both IgE and type 2 cytokines are
increased, with some degree of overlap with other phenotypes. Systematic reviews …
increased, with some degree of overlap with other phenotypes. Systematic reviews …
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in …
Dupilumab, a fully human monoclonal antibody against interleukin‐4 receptor α, is approved
as add‐on maintenance treatment for inadequately controlled type 2 severe asthma. This …
as add‐on maintenance treatment for inadequately controlled type 2 severe asthma. This …
Efficacy and safety of dupilumab for moderate‐to‐severe atopic dermatitis: a systematic review for the EAACI biologicals guidelines
This systematic review evaluates the efficacy, safety and economic impact of dupilumab
compared to standard of care for uncontrolled moderate‐to‐severe atopic dermatitis (AD) …
compared to standard of care for uncontrolled moderate‐to‐severe atopic dermatitis (AD) …
Economic evaluation of cognitive behavioural therapy for insomnia (CBT-I) for improving health outcomes in adult populations: a systematic review
Cognitive behavioural therapy for insomnia (CBT-I) is a promising intervention with
established efficacy, yet evidence of its cost-effectiveness remains unclear. Systematic …
established efficacy, yet evidence of its cost-effectiveness remains unclear. Systematic …
Systematic mapping of checklists for assessing transferability
H Munthe-Kaas, H Nøkleby, L Nguyen - Systematic reviews, 2019 - Springer
Background Systematic reviews of research evidence have become an expected basis for
decisions about practice guidelines and policy decisions in the health and welfare sectors …
decisions about practice guidelines and policy decisions in the health and welfare sectors …
Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application
R Goeree, J He, D O'Reilly, JE Tarride… - ClinicoEconomics …, 2011 - Taylor & Francis
Background: Health technology assessments (HTA) generally, and economic evaluations
(EE) more specifically, have become an integral part of health care decision making around …
(EE) more specifically, have become an integral part of health care decision making around …
[HTML][HTML] Strengthening and implementing health technology assessment and the decision-making process in the Region of the Americas
Objective Health technology assessment (HTA) has been adopted by countries in order to
improve allocative efficiency in their health systems. This study aimed to describe and …
improve allocative efficiency in their health systems. This study aimed to describe and …
Cost-of-illness studies in nine Central and Eastern European countries
Background To date, a multi-country review evaluating the cost-of-illness (COI) studies from
the Central and Eastern European (CEE) region has not yet been published. Our main …
the Central and Eastern European (CEE) region has not yet been published. Our main …